🧪 Hypotheses

155 hypotheses generated by SciDEX — searchable by gene, disease, or keyword

155
Total Hypotheses
0.65
Avg Score
0.56
Avg Feasibility
All therapeutic (155)mechanistic (0)diagnostic (0)methodological (0)
Sort: ScoreFeasibilityNoveltyImpactNewest
therapeutic 1.00
APOE4-Specific Lipidation Enhancement Therapy
🧬 APOE 🏥 Alzheimer's disease
✅ 0.00 ✨ 0.00 💥 0.00
## Molecular Mechanism and Rationale...
therapeutic 0.94
Metabolic Reprogramming to Reverse Senescence
🧬 SIRT1,PGC1A,NAMPT 🏥 N/A
✅ 0.90 ✨ 0.60 💥 0.00
# Metabolic Reprogramming to Reverse Senescence in Neurodegeneration: A Mechanistic Hypothesis...
therapeutic 0.91
Closed-loop focused ultrasound targeting EC-II SST interneurons to restore gamma gating and block tau propagation in AD
🧬 SST 🏥 Alzheimer's disease
✅ 0.87 ✨ 0.79 💥 0.81
## Molecular Mechanism and Rationale...
therapeutic 0.90
Closed-loop tACS targeting EC-II SST interneurons to block tau propagation and restore perforant-path gamma gating in AD
🧬 SST 🏥 Alzheimer's disease
✅ 0.86 ✨ 0.78 💥 0.82
## Molecular Mechanism and Rationale...
therapeutic 0.89
Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95 palmitoylation stabilization
🧬 BDNF 🏥 Alzheimer's disease
✅ 0.70 ✨ 0.82 💥 0.83
## Molecular Mechanism and Rationale...
therapeutic 0.88
LRP1-Dependent Tau Uptake Disruption
🧬 LRP1 🏥 neurodegeneration
✅ 0.00 ✨ 0.00 💥 0.00
# LRP1-Dependent Tau Uptake Disruption in Tauopathic Neurodegeneration...
therapeutic 0.87
SASP Modulation Rather Than Cell Elimination
🧬 NFKB1,IL1B,BDNF 🏥 N/A
✅ 0.80 ✨ 0.70 💥 0.00
# SASP Modulation Rather Than Cell Elimination...
therapeutic 0.87
Closed-loop tACS targeting EC-II PV interneurons to suppress burst firing and block tau propagation via perforant path i
🧬 PVALB 🏥 Alzheimer's disease
✅ 0.87 ✨ 0.78 💥 0.81
## Molecular Mechanism and Rationale...
therapeutic 0.87
Beta-frequency entrainment therapy targeting PV interneuron-astrocyte coupling for tau clearance
🧬 SST 🏥 Alzheimer's disease
✅ 0.85 ✨ 0.82 💥 0.82
## Molecular Mechanism and Rationale...
therapeutic 0.86
Selective Acid Sphingomyelinase Modulation Therapy
🧬 SMPD1 🏥 neurodegeneration
✅ 0.90 ✨ 0.70 💥 0.85
**Overview**...
therapeutic 0.86
Palmitoylethanolamide-Based Endocannabinoid Therapy
🧬 PPARA 🏥 N/A
✅ 0.00 ✨ 0.00 💥 0.00
**Background and Rationale**...
therapeutic 0.85
Closed-loop tACS targeting EC-II parvalbumin interneurons to restore gamma rhythmogenesis and block tau AIS disruption i
🧬 PVALB 🏥 Alzheimer's disease
✅ 0.86 ✨ 0.79 💥 0.80
## Molecular Mechanism and Rationale...
therapeutic 0.84
CYP46A1 Overexpression Gene Therapy
🧬 CYP46A1 🏥 neurodegeneration
✅ 0.60 ✨ 0.95 💥 0.90
**CYP46A1 Overexpression Gene Therapy for Alzheimer's Disease**...
therapeutic 0.84
Dual-Receptor Antibody Shuttling
🧬 N/A 🏥 Alzheimer's disease
✅ 0.00 ✨ 0.00 💥 0.00
# Dual-Receptor Antibody Shuttling: A Strategic Approach to Overcoming Blood-Brain Barrier Limitations in Neurodegenerative Disease Therapy...
therapeutic 0.83
Autophagy-Senescence Axis Therapeutic Window
🧬 ATG7,BCL2,BCL2L1 🏥 N/A
✅ 0.60 ✨ 0.80 💥 0.00
# Autophagy-Senescence Axis Therapeutic Window: Sequential Targeting of ATG7 and BCL-2 Family Proteins in Neurodegeneration...
therapeutic 0.82
APOE-Dependent Autophagy Restoration
🧬 MTOR 🏥 neurodegeneration
✅ 0.90 ✨ 0.60 💥 0.80
APOE-Dependent Autophagy Restoration proposes targeting the mechanistic link between apolipoprotein E4 (APOE4) genotype and impaired macroautophagy as...
therapeutic 0.82
Closed-loop transcranial alternating current stimulation to restore hippocampal-prefrontal gamma synchrony via PV intern
🧬 SST 🏥 Alzheimer's disease
✅ 0.88 ✨ 0.78 💥 0.81
## Molecular Mechanism and Rationale...
therapeutic 0.81
Circadian Glymphatic Entrainment via Targeted Orexin Receptor Modulation
🧬 HCRTR1/HCRTR2 🏥 neurodegeneration
✅ 0.90 ✨ 0.75 💥 0.80
**Overview**...
therapeutic 0.80
Closed-loop focused ultrasound targeting CA1 PV interneurons to restore theta-gamma coupling and block synaptotoxic Aβ o
🧬 PVALB 🏥 Alzheimer's disease
✅ 0.65 ✨ 0.88 💥 0.78
## Molecular Mechanism and Rationale...
therapeutic 0.80
Closed-loop transcranial focused ultrasound targeting EC-II SST interneurons to prevent tau propagation and restore ento
🧬 SST 🏥 Alzheimer's disease
✅ 0.45 ✨ 0.90 💥 0.80
## Molecular Mechanism and Rationale...
therapeutic 0.78
Senescence-Activated NAD+ Depletion Rescue
🧬 CD38/NAMPT 🏥 neurodegeneration
✅ 0.70 ✨ 0.75 💥 0.75
**Molecular Mechanism and Rationale**...
therapeutic 0.77
Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflammatory Priming
🧬 TLR4 🏥 neurodegeneration
✅ 0.80 ✨ 0.70 💥 0.70
Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflammatory Priming proposes targeting the Toll-like receptor 4 (TLR4) signaling axis as the cr...
therapeutic 0.77
AMPK hypersensitivity in astrocytes creates enhanced mitochondrial rescue responses
🧬 PRKAA1 🏥 neurodegeneration
✅ 0.85 ✨ 0.80 💥 0.75
**AMPK Hypersensitivity Engineering for Neuroprotection: Astrocyte-Mediated Mitochondrial Rescue**...
therapeutic 0.77
Prefrontal sensory gating circuit restoration via PV interneuron enhancement
🧬 PVALB 🏥 Alzheimer's disease
✅ 0.70 ✨ 0.72 💥 0.73
## Molecular Mechanism and Rationale...
therapeutic 0.76
CYP46A1 Gene Therapy for Age-Related TREM2-Mediated Microglial Senescence Reversal
🧬 CYP46A1 🏥 neurodegeneration
✅ 0.60 ✨ 0.75 💥 0.80
## Molecular Mechanism and Rationale...
therapeutic 0.76
Selective Neutral Sphingomyelinase-2 Inhibition Therapy
🧬 SMPD3 🏥 neurodegeneration
✅ 0.00 ✨ 0.00 💥 0.00
This hypothesis proposes selective pharmacological inhibition of neutral sphingomyelinase-2 (nSMase2, encoded by SMPD3) to prevent pathological cerami...
therapeutic 0.75
Closed-loop tACS targeting EC-II PV interneurons to enhance perisomatic inhibition and block tau propagation in AD
🧬 PVALB 🏥 Alzheimer's disease
✅ 0.65 ✨ 0.78 💥 0.75
## Molecular Mechanism and Rationale...
therapeutic 0.75
Neutrophil Extracellular Trap (NET) Inhibition
🧬 PADI4 🏥 N/A
✅ 0.00 ✨ 0.00 💥 0.00
**Background and Rationale**...
therapeutic 0.75
Circadian-Synchronized Proteostasis Enhancement
🧬 CLOCK/ULK1 🏥 neurodegeneration
✅ 0.60 ✨ 0.80 💥 0.70
# Detailed Scientific Description: Circadian-Synchronized Proteostasis Enhancement...
therapeutic 0.75
Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modulation
🧬 FCGRT 🏥 neurodegeneration
✅ 0.70 ✨ 0.60 💥 0.60
**Molecular Mechanism and Rationale**...
Loading more hypotheses...